Roche immunoassay for highly sensitive myocardial rotation protein T - Taiwan Registration 181280742cabbf7953045e067a9a4246
Access comprehensive regulatory information for Roche immunoassay for highly sensitive myocardial rotation protein T in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 181280742cabbf7953045e067a9a4246 and manufactured by ROCHE DIAGNOSTICS GMBH. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including ROCHE DIAGNOSTICS GMBH, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product uses electrochemiluminescence immunoassay (ECLIA) to quantitatively detect human serum and plasma central myorotation protein T (Troponin T) content on cobas e immunoassay in vitro.
A Clinical chemistry and clinical toxicology
A.1215 Creatine phosphokinase/creatine kinase or isoenzyme testing system; A.1150 calibration
QMS/QSD;; ่ผธๅ ฅ
Dates and Status
Dec 29, 2022
Dec 29, 2027